Ozanimod
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for Ozanimod, covering 2019-02-06 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis [Phase 2, Phase 3]